Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion
Ami Fadia

Ami Fadia Analyst Performance

Sr Biotech Equity Research Analyst at Needham & Company LLC

Ami Fadia is a stock analyst at Needham & Company LLC focused in the medical sector, covering 26 publicly traded companies. Over the past year, Ami Fadia has issued 79 stock ratings, including buy and hold recommendations. While full access to Ami Fadia's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ami Fadia's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
154 Last 6 Years
Buy Recommendations
89.93% 134 Buy Ratings
Companies Covered
26 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy89.9%134 ratings
Hold10.1%14 ratings
Sell0.0%0 ratings

Out of 149 total stock ratings issued by Ami Fadia at Needham & Company LLC, the majority (89.9%) have been Buy recommendations, followed by 10.1% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
26 companies

Ami Fadia, an analyst at Needham & Company LLC, currently covers 26 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
25 companies
96.2%
Manufacturing
1 company
3.8%

Ami Fadia of Needham & Company LLC specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
18 companies
69.2%
MED - DRUGS
5 companies
19.2%
Miscellaneous
1 company
3.8%
MED - OUTP/HM CRE
1 company
3.8%
BIOTECHNOLOGY
1 company
3.8%

About Ami Fadia

Ami Fadia joined Needham and Company in May 2021 covering Biotechnology with a focus on targeted oncology and neuroscience. Prior to joining Needham, Ami spent four years as a Managing Director and Senior Analyst at SVB Leerink and previous to that spent six years at UBS where she most recently held the position of Senior Analyst. Ami also spent time working in industry as Head of Strategy & Operations at Sandoz where she was responsible for building a high performing team responsible for strategic planning, sales force strategy, training, project management, budgeting, and business development. Ami began her career in consulting working at KPMG and then McKinsey & Company in their healthcare practice. Ami holds an MBA from the Kellogg School of Management, her Bachelor’s of Commerce from the Shri Ram College, Delhi University and is a member of the Institute of Chartered Accountants of India.
Follow on LinkedIn

Ami Fadia's Ratings History at Needham & Company LLC

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Alkermes plc stock logo
ALKS
Alkermes
5/6/2026Boost Price Target$36.25$50.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
5/5/2026Boost Price Target$230.28$255.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
5/1/2026Boost Price Target$205.83$255.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
4/14/2026Reiterated Rating$343.28$510.00Buy
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
4/8/2026Initiated Coverage$24.14$37.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/6/2026Reiterated Rating$133.30$185.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
3/31/2026Reiterated Rating$1.93$8.00Buy
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
3/31/2026Downgrade$27.58Hold
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
3/18/2026Lower Price Target$5.07$15.00Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
3/9/2026Reiterated Rating$3.39$14.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
3/9/2026Reiterated Rating$5.33$11.00Buy
GH Research PLC stock logo
GHRS
GH Research
3/6/2026Boost Price Target$15.17$32.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
3/6/2026Downgrade$21.18Hold
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
2/25/2026Lower Price Target$12.02$17.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
2/25/2026Lower Price Target$28.19$44.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/23/2026Reiterated Rating$183.72$225.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/12/2026Lower Price Target$137.44$185.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/4/2026Boost Price Target$310.52$510.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
1/12/2026Boost Price Target$161.13$235.00Buy
GH Research PLC stock logo
GHRS
GH Research
1/6/2026Set Price Target$15.46$29.00
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
1/5/2026Reiterated Rating$286.40$460.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/5/2026Reiterated Rating$178.69$225.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
1/5/2026Reiterated Rating$26.29$34.00Buy
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
1/5/2026Reiterated Rating$13.64Buy
GH Research PLC stock logo
GHRS
GH Research
1/5/2026Reiterated Rating$13.24$19.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
12/31/2025Boost Price Target$148.79$169.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/8/2025Boost Price Target$247.99$315.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
12/8/2025Reiterated Rating$39.79Hold
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/5/2025Set Price Target$253.44$304.00
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/1/2025Reiterated Rating$196.71$250.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
11/24/2025Reiterated Rating$34.67$42.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
11/24/2025Reiterated Rating$8.56$16.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
11/6/2025Boost Price Target$22.33$29.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
11/6/2025Boost Price Target$59.34$72.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
11/4/2025Reiterated Rating$135.75$154.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
10/29/2025Boost Price Target$147.38$184.00Buy
Alkermes plc stock logo
ALKS
Alkermes
10/29/2025Boost Price Target$31.00$44.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
10/28/2025Boost Price Target$2.69$8.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
10/22/2025Downgrade$18.58Hold
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
10/16/2025Boost Price Target$175.68$250.00Buy
From the man who predicted 2008 crash… (Ad)

Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the biggest story of his 26-year career - an economic shift not seen since 1776. From the government taking stakes in Intel, Lithium Americas, and MP Materials, to sweeping political changes reshaping the economy, Stansberry argues a rare 'New 1776 Moment' is already underway. One Nobel Prize winner calls it a dividing line for all of society. His presentation covers the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Watch Porter Stansberry's full briefing and learn how to prepare now
GH Research PLC stock logo
GHRS
GH Research
10/13/2025Initiated Coverage$12.59$19.00Buy
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
10/13/2025Set Price Target$11.81$28.00Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
10/13/2025Initiated Coverage$5.10$12.00Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
10/13/2025Initiated Coverage$5.40$12.00Buy
GH Research PLC stock logo
GHRS
GH Research
10/13/2025Initiated Coverage$12.96$19.00Buy
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
10/13/2025Initiated Coverage$12.25$28.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
9/30/2025Reiterated Rating$6.75$11.00Buy
Merus N.V. stock logo
MRUS
Merus
9/29/2025Downgrade$94.15$96.00Hold
Biogen Inc. stock logo
BIIB
Biogen
9/24/2025Reiterated Rating$139.31Hold
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
9/24/2025Lower Price Target$28.74$41.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
9/24/2025Lower Price Target$20.84$28.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
9/22/2025Boost Price Target$145.23$170.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
9/15/2025Boost Price Target$8.49$11.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
9/11/2025Boost Price Target$40.45$66.00Buy
Alkermes plc stock logo
ALKS
Alkermes
9/9/2025Set Price Target$26.93$43.00
Biogen Inc. stock logo
BIIB
Biogen
9/4/2025Reiterated Rating$141.62Hold
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
8/28/2025Reiterated Rating$124.43$202.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
8/26/2025Reiterated Rating$5.95$8.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
8/20/2025Reiterated Rating$119.20$202.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
8/7/2025Lower Price Target$36.67$56.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
8/6/2025Lower Price Target$6.88$16.00Buy
Merus N.V. stock logo
MRUS
Merus
8/6/2025Lower Price Target$67.45$96.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
8/4/2025Reiterated Rating$103.02$150.00Buy
Alkermes plc stock logo
ALKS
Alkermes
7/29/2025Reiterated Rating$26.15$45.00Buy
Alkermes plc stock logo
ALKS
Alkermes
7/21/2025Reiterated Rating$29.22$45.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
6/26/2025Reiterated Rating$22.50$30.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
6/24/2025Reiterated Rating$40.42$57.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
6/18/2025Reiterated Rating$1.82$9.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
6/17/2025Reiterated Rating$7.49Hold
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
6/16/2025Reiterated Rating$6.70Hold
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
6/12/2025Reiterated Rating$44.60$80.00Buy
Biogen Inc. stock logo
BIIB
Biogen
6/12/2025Reiterated Rating$133.06Hold
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
6/11/2025Reiterated Rating$113.00$202.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
6/9/2025Lower Price Target$111.91$150.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
6/5/2025Reiterated Rating$1.96$9.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
6/3/2025Reiterated Rating$108.29$202.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
6/2/2025Downgrade$101.15$130.00Hold
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
5/28/2025Initiated Coverage$12.77$35.00Buy
Alkermes plc stock logo
ALKS
Alkermes
5/28/2025Initiated Coverage$29.90$45.00Buy
Merus N.V. stock logo
MRUS
Merus
5/19/2025Reiterated Rating$41.56$75.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
5/19/2025Boost Price Target$22.26$30.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
5/13/2025Reiterated Rating$0.72$5.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
5/8/2025Reiterated Rating$37.66$57.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
5/8/2025Reiterated Rating$9.47$19.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
5/7/2025Lower Price Target$6.99$27.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
5/7/2025Reiterated Rating$111.17$200.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
5/6/2025Reiterated Rating$29.96$49.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
5/5/2025Reiterated Rating$40.24$80.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
5/2/2025Reiterated Rating$9.08$29.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
4/28/2025Lower Price Target$87.20$130.00Buy
Read this warning immediately (Ad)

Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Read Porter Stansberry's full breakdown and protect your wealth now
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
4/25/2025Reiterated Rating$7.79Hold
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/15/2025Upgrade$94.89$138.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
4/10/2025Reiterated Rating$110.12$210.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
4/10/2025Reiterated Rating$1.29$12.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
4/10/2025Reiterated Rating$0.76$5.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
4/9/2025Reiterated Rating$6.59$19.00Buy
Merus N.V. stock logo
MRUS
Merus
4/9/2025Reiterated Rating$34.89$83.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
4/9/2025Reiterated Rating$6.38$30.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
4/8/2025Reiterated Rating$14.61$28.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
4/8/2025Reiterated Rating$80.20$133.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
4/8/2025Reiterated Rating$31.53$85.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
4/8/2025Reiterated Rating$31.40$59.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
4/8/2025Reiterated Rating$28.91$50.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
4/1/2025Reiterated Rating$116.63$153.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
3/21/2025Reiterated Rating$1.65$12.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
3/11/2025Reiterated Rating$9.79$30.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
3/5/2025Reiterated Rating$140.69$210.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
3/4/2025Reiterated Rating$1.41$5.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
3/3/2025Lower Price Target$38.60$85.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
3/3/2025Reiterated Rating$7.91$19.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
3/3/2025Reiterated Rating$129.15$153.00Buy
Merus N.V. stock logo
MRUS
Merus
2/28/2025Lower Price Target$46.22$83.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2/27/2025Reiterated Rating$18.96$28.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
2/27/2025Lower Price Target$40.50$59.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
2/26/2025Reiterated Rating$11.10$30.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
2/26/2025Reiterated Rating$11.82$32.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
2/26/2025Boost Price Target$139.67$210.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
2/25/2025Reiterated Rating$34.18$50.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/19/2025Boost Price Target$128.09$153.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
2/19/2025Lower Price Target$36.76$50.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
2/13/2025Reiterated Rating$103.56$133.00Buy
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
2/12/2025Reiterated Rating$7.19Hold
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/10/2025Reiterated Rating$86.88$150.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/10/2025Reiterated Rating$131.74$133.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/7/2025Reiterated Rating$150.51Hold
Immuneering Corporation stock logo
IMRX
Immuneering
2/6/2025Reiterated Rating$2.03$12.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
1/13/2025Reiterated Rating$87.43$135.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
1/13/2025Reiterated Rating$35.91$52.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
1/13/2025Reiterated Rating$14.75$32.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
1/13/2025Reiterated Rating$1.99$15.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
1/13/2025Reiterated Rating$11.77$33.00Buy